Schedule 13D ownership disclosure

Oncobiologics, Inc.

Security class unavailable · CUSIP: 68235M105

Event date: 2017-10-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
68.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-17-000864
Form type
SC 13D/A
Filer
BioLexis Pte Ltd.
CIK
CIK 1716335
Filed
Nov 01, 2017
Reporting period
Oct 31, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub